“Eicosapentaenoic acid inhibits oxidation of high density lipoprotein particles in a manner distinct from docosahexaenoic acid”. Biochemical and Biophysical Research Communications496 (2). (2018). doi:10.1016/j.bbrc.2018.01.062.
Yokoyama, M.; Origasa, H.; Matsuzaki, M. et al. (2007). “Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis”. Lancet369 (9567): 1090–1098. doi:10.1016/S0140-6736(07)60527-3. PMID17398308.
Yokoyama, M.; Origasa, H.; Matsuzaki, M. et al. (2007). “Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis”. Lancet369 (9567): 1090–1098. doi:10.1016/S0140-6736(07)60527-3. PMID17398308.